FDA investigates possible Vytorin link to cancer
Thursday, August 21, 2008 - 16:35
in Health & Medicine
WASHINGTON -- Federal drug safety regulators said Thursday they are investigating whether the cholesterol-lowering drug Vytorin can increase patients' risk of developing cancer.